Shaping opportunities for future clinical trials in tuberculosis
- PMID: 40915310
- DOI: 10.1016/S1473-3099(25)00479-7
Shaping opportunities for future clinical trials in tuberculosis
Conflict of interest statement
IN and NH report payments by LigaChem Biosciences to their institution for clinical evaluation of delpazolid. All other authors declare no competing interests. The authors are part of the PanACEA TB trials consortium; which is funded by the EDCTP2 programme (grant number TRIA2015–1102) supported by the EU with assistance from the German Ministry for Education and Research (01KA1701) and Nederlandse Organisatie voor Wetenschappelijk Onderzoek.
LinkOut - more resources
Full Text Sources